IEQ Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.44M Buy
15,555
+6,168
+66% +$1.35M 0.01% 637
2026
Q2
$1.83M Buy
+9,387
New +$1.95M 0.01% 839
2025
Q4
– Sell
-6,222
Closed -$1.7M – 1982
2025
Q3
$1.7M Sell
6,222
-842
-12% -$230K 0.01% 816
2025
Q2
$1.82M Sell
7,064
-9,918
-58% -$2.37M 0.01% 671
2025
Q1
$3.8M Sell
16,982
-22,711
-57% -$5.3M 0.03% 407
2024
Q4
$9.08M Buy
39,693
+25,730
+184% +$6.2M 0.09% 147
2024
Q3
$3.41M Buy
13,963
+1,697
+14% +$379K 0.04% 263
2024
Q2
$2.35M Buy
12,266
+563
+5% +$114K 0.03% 307
2024
Q1
$2.32M Buy
11,703
+424
+4% +$77.7K 0.03% 298
2023
Q4
$1.94M Buy
11,279
+5,173
+85% +$795K 0.03% 296
2023
Q3
$903K Buy
6,106
+3,314
+119% +$599K 0.02% 425
2023
Q2
$610K Sell
2,792
-121
-4% -$27K 0.01% 505
2023
Q1
$638K Buy
2,913
+512
+21% +$111K 0.01% 496
2022
Q4
$500K Sell
2,401
-1,277
-35% -$281K 0.01% 513
2022
Q3
$803K Buy
3,678
+2,012
+121% +$458K 0.02% 415
2022
Q2
$349K Sell
1,666
-516
-24% -$110K 0.01% 561
2022
Q1
$529K Buy
2,182
+435
+25% +$105K 0.01% 485
2021
Q4
$455K Sell
1,747
-166
-9% -$43.1K 0.01% 487
2021
Q3
$504K Buy
1,913
+644
+51% +$176K 0.01% 431
2021
Q2
$313K Buy
+1,269
New +$267K 0.01% 451

Other funds holding RMD

IEQ Capital's RMD Position: Q3 2026 in Review

IEQ Capital increased its ResMed (RMD) stake by 66% in Q3 2026, buying an estimated $1.35M and bringing the position to 15,555 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #637.

IEQ Capital first reported a position in RMD in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.08M in Q4 2024. 865 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • IEQ Capital held 15,555 shares of ResMed worth $3.44M as of Q3 2026.
  • IEQ Capital bought 6,168 ResMed shares in Q3 2026, an estimated $1.35M.
  • ResMed made up 0.01% of IEQ Capital's portfolio in Q3 2026, its #637 holding.
  • IEQ Capital first reported a position in ResMed in Q2 2021 and has held it in 20 quarters since.
  • IEQ Capital's ResMed position peaked at $9.08M in Q4 2024.
  • 865 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.